Merit Medical Systems (MMSI)
(Delayed Data from NSDQ)
$88.74 USD
+4.62 (5.49%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $88.71 -0.03 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
MMSI 88.74 +4.62(5.49%)
Will MMSI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MMSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MMSI
Merit Medical (MMSI) Q2 Earnings & Revenues Beat, '24 View Up
Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
MMSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merit Medical (MMSI) Q2 Earnings and Revenues Beat Estimates
BDX vs. MMSI: Which Stock Should Value Investors Buy Now?
Cardinal Health (CAH) Recalls Kits Containing Shenli's Syringes
Other News for MMSI
Merit Medical Systems, Inc. (MMSI) Q2 2024 Earnings Call Transcript
Buy Rating Affirmed for Merit Medical Systems on Strong Q2 Performance and Upbeat Financial Outlook
Merit Medical price target raised by $3 at Piper Sandler, here's why
Assessing Merit Medical Systems: Insights From 6 Financial Analysts
Merit Medical Systems Inc (MMSI) Q2 2024 Earnings Call Transcript Highlights: Record Free Cash ...